Intuitive Surgical (ISRG) Stock Price, News & Analysis

Company Overview

Intuitive Surgical, Inc. is a pioneer in the design, development and manufacture of robotic-assisted surgical systems aimed at enabling minimally invasive surgery. Headquartered in Sunnyvale, California, the company’s flagship offering is the da Vinci Surgical System, which integrates advanced robotics, 3D visualization and ergonomic surgeon controls to facilitate precision procedures. Intuitive also offers the Ion endoluminal system for minimally invasive biopsy in lung procedures, as well as a suite of specialized instruments, accessories and maintenance services that support a broad range of clinical applications.

The da Vinci Surgical System comprises a surgeon console, patient-side cart and vision cart, allowing surgeons to perform complex procedures through small incisions with enhanced dexterity and control. Intuitive’s EndoWrist instruments replicate the natural motion of the human wrist, while its proprietary 3D high-definition camera provides detailed visualization of the surgical field. Beyond hardware, the company delivers training modules, performance tracking tools and ongoing technical support to help hospitals and surgical teams optimize outcomes and streamline workflow.

Since receiving initial FDA clearance in 2000, Intuitive Surgical has expanded its footprint across more than 70 countries, with regional operations spanning North America, Europe, Asia-Pacific, Latin America, the Middle East and Africa. Its systems are used in specialties including urology, gynecology, general surgery, thoracic, cardiac and bariatric surgery. Through strategic partnerships with healthcare institutions and academic medical centers, the company continues to foster clinical research, training programs and product innovations in robotic surgery.

Founded in 1995 by Frederic Moll, John Freund and Robert Younge, Intuitive Surgical has grown from a small start-up into a leader in surgical robotics. The company is led by President and Chief Executive Officer Gary S. Guthart, under whose tenure Intuitive has introduced newer generations of its da Vinci platform and diversified into image-guided therapy. With a focus on improving patient outcomes and reducing recovery times, Intuitive remains at the forefront of medical technology innovation in the global healthcare industry.

Key Stats

• Today's Range: $531.68 to $545.81
• 50-Day Range: $478.74 to $565.94
• 52-Week Range: $413.82 to $616.00
• Volume: 1.64 million shs
• Average Volume: 1.67 million shs
• Market Capitalization: $192.83 billion
• P/E Ratio: 78.88
• Dividend Yield: N/A
• Price Target: $588.95
• Consensus Rating: Moderate Buy

Intuitive Surgical Stock Analysis - MarketRank™

Intuitive Surgical scored higher than 94% of companies evaluated by MarketBeat, and ranked 149th out of 943 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.4 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

Intuitive Surgical has received a consensus rating of Moderate Buy. The company's average rating score is 2.70, and is based on 15 buy ratings, 4 hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Intuitive Surgical has been the subject of 10 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 1.9 / 5
• Proj. Earnings Growth: 18.66%

Earnings Growth

Earnings for Intuitive Surgical are expected to grow by 18.66% in the coming year, from $6.43 to $7.63 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of Intuitive Surgical is 78.48, which means that it is trading at a more expensive P/E ratio than the market average P/E ratio of about 24.90.

Price to Earnings Ratio vs. Sector

The P/E ratio of Intuitive Surgical is 78.48, which means that it is trading at a more expensive P/E ratio than the Medical sector average P/E ratio of about 26.50.

Price to Earnings Growth Ratio

Intuitive Surgical has a PEG Ratio of 5.66. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

Intuitive Surgical has a P/B Ratio of 11.53. P/B Ratios above 3 indicate that a company could be overvalued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

1.12% of the float of Intuitive Surgical has been sold short.

Short Interest Ratio / Days to Cover

Intuitive Surgical has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Intuitive Surgical has recently increased by 1.79%, indicating that investor sentiment is decreasing.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Intuitive Surgical does not currently pay a dividend.

Dividend Growth

Intuitive Surgical does not have a long track record of dividend growth.

Sustainability and ESG

• Score: 4.0 / 5
• Environmental Score: -1.15

Percentage of Shares Shorted

1.12% of the float of Intuitive Surgical has been sold short.

Short Interest Ratio / Days to Cover

Intuitive Surgical has a short interest ratio ("days to cover") of 2, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in Intuitive Surgical has recently increased by 1.79%, indicating that investor sentiment is decreasing.

News and Social Media

• Score: 3.1 / 5
• News Sentiment: 1.51

News Sentiment

Intuitive Surgical has a news sentiment score of 1.51. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.89 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 55 news articles for Intuitive Surgical this week, compared to 34 articles on an average week.

Search Interest

Only 43 people have searched for ISRG on MarketBeat in the last 30 days. This is a decrease of -23% compared to the previous 30 days.

MarketBeat Follows

Only 17 people have added Intuitive Surgical to their MarketBeat watchlist in the last 30 days. This is a decrease of -23% compared to the previous 30 days.

Company Ownership

• Score: 2.5 / 5
• Insider Trading: Selling Shares

Insider Buying vs. Insider Selling

In the past three months, Intuitive Surgical insiders have sold more of their company's stock than they have bought. Specifically, they have bought $0.00 in company stock and sold $2,611,577.00 in company stock.

Percentage Held by Insiders

Only 0.70% of the stock of Intuitive Surgical is held by insiders.

Percentage Held by Institutions

83.64% of the stock of Intuitive Surgical is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

ISRG Stock Analysis - Frequently Asked Questions

How have ISRG shares performed this year?

Intuitive Surgical's stock was trading at $521.96 at the beginning of the year. Since then, ISRG shares have increased by 2.5% and is now trading at $535.2550.
View the best growth stocks for 2025 here.

How were Intuitive Surgical's earnings last quarter?

Intuitive Surgical, Inc. (NASDAQ:ISRG) announced its earnings results on Tuesday, April, 22nd. The medical equipment provider reported $1.81 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.71 by $0.10. The medical equipment provider had revenue of $2.25 billion for the quarter, compared to analysts' expectations of $2.19 billion. Intuitive Surgical had a trailing twelve-month return on equity of 14.43% and a net margin of 28.41%.
Read the conference call transcript.

When did Intuitive Surgical's stock split?

Intuitive Surgical shares split on the morning of Tuesday, October 5th 2021.The 3-1 split was announced on Thursday, August 5th 2021. The newly issued shares were payable to shareholders after the closing bell on Monday, October 4th 2021. An investor that had 100 shares of stock prior to the split would have 300 shares after the split.

Does Intuitive Surgical have any subsidiaries?

Intuitive Surgical subsidiaries include Orpheus Medical, NeoGuide Systems, Computer Motion, Intuitive Surgical AB, Intuitive Surgical ApS, Intuitive Surgical Australia Proprietary Limited, Intuitive Surgical Brasil Importacao E Comercio De Equipamentos Cirurgicos Ltda, and more.

Who are Intuitive Surgical's major shareholders?

Top institutional shareholders of Intuitive Surgical include Rowlandmiller & PARTNERS.ADV. Insiders that own company stock include David J Rosa, Marshall Mohr, Alan J Levy, Gary S Guthart, Mark J Rubash, Amal M Johnson, Jamie Samath, Jami K Nachtsheim, Brian Edward Miller, Robert Desantis, Henry L Charlton, Gary Loeb, Mark Brosius, Amy L Ladd, Fredrik Widman, Myriam Curet and Craig H Barratt.
View institutional ownership trends.

How do I buy shares of Intuitive Surgical?

Shares of ISRG stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

What other stocks do shareholders of Intuitive Surgical own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Intuitive Surgical investors own include BlackRock (BLK), Broadcom (AVGO), ServiceNow (NOW), NVIDIA (NVDA), UnitedHealth Group (UNH), The Goldman Sachs Group (GS) and Meta Platforms (META).

Company Calendar

• Last Earnings: 4/22/2025
• Today: 7/01/2025
• Next Earnings (Estimated): 7/17/2025
• Fiscal Year End: 12/31/2025

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED INSTRUMENTS
• Sub-Industry: Health Care Equipment
• Current Symbol: NASDAQ:ISRG
• CIK: 1035267
• Web: www.intuitive.com
• Phone: (408) 523-2100
• Fax: 408-523-1390
• Employees: 15,638
• Year Founded: 1995

Price Target and Rating

• Average Stock Price Target: $588.95
• High Stock Price Target: $700.00
• Low Stock Price Target: $440.00
• Potential Upside/Downside: +8.8%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.70
• Research Coverage: 20 Analysts

Profitability

• EPS (Most Recent Fiscal Year): $6.82
• Trailing P/E Ratio: 79.36
• Forward P/E Ratio: 84.18
• P/E Growth: 5.66
• Net Income: $2.32 billion
• Net Margins: 28.41%
• Pretax Margin: 32.17%
• Return on Equity: 14.43%
• Return on Assets: 12.81%

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: 4.98
• Quick Ratio: 3.97

Sales & Book Value

• Annual Sales: $8.35 billion
• Price / Sales: 23.23
• Cash Flow: $8.10 per share
• Price / Cash Flow: 66.81
• Book Value: $46.41 per share
• Price / Book: 11.66

Miscellaneous

• Outstanding Shares: 358,420,000
• Free Float: 355,909,000
• Market Cap: $194.00 billion
• Optionable: Optionable
• Beta: 1.67